Published in Medical Letter on the CDC and FDA, May 24th, 2006
Researchers in Italy conducted a study "to investigate the impact of early versus deferred combined antiretroviral treatment (ART) in asymptomatic or moderately symptomatic [Centers for Disease Control and Prevention (CDC) category N, A, or B] infants with perinatal HIV-1 infection."
Elena Chiappini at the University of Florence and collaborators explained, "A multicenter nationwide case-control study was conducted. Data from 30...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.